Septerna (NASDAQ:SEPN) Price Target Raised to $60.00

Key Points

• HC Wainwright raised Septerna’s price target from $40 to $60 and maintained a “buy” rating, implying 25.63% upside from the prior close.
• Analyst sentiment remains positive, with Septerna carrying a “Moderate Buy” consensus rating and an average price target of $49, although one analyst rated it a sell.
• Septerna beat quarterly expectations, reporting an adjusted loss of $0.29 per share versus estimates of $0.43 and revenue of $26.75 million versus $19.22 million expected.

Septerna (NASDAQ:SEPN - Get Free Report) had its price objective hoisted by analysts at HC Wainwright from $40.00 to $60.00 in a research note issued on Wednesday, Marketbeat.com reports. The firm presently has a "buy" rating on the stock. HC Wainwright's price target suggests a potential upside of 25.63% from the stock's previous close.

A number of other research analysts have also weighed in on the stock. Stifel Nicolaus set a $49.00 price target on shares of Septerna in a research note on Tuesday. Truist Financial lifted their target price on shares of Septerna from $35.00 to $43.00 and gave the stock a "buy" rating in a research note on Wednesday, July 1st. Raymond James Financial reaffirmed a "strong-buy" rating and set a $49.00 target price on shares of Septerna in a report on Tuesday. Weiss Ratings reissued a "sell (d-)" rating on shares of Septerna in a research note on Friday, July 17th. Finally, Guggenheim boosted their price target on shares of Septerna from $45.00 to $51.00 and gave the stock a "buy" rating in a research report on Tuesday. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $49.00.

Septerna Price Performance

Shares of SEPN stock opened at $47.76 on Wednesday. Septerna has a 1-year low of $10.62 and a 1-year high of $48.00. The company has a market cap of $2.15 billion, a price-to-earnings ratio of -88.44 and a beta of 2.29. The stock has a 50 day simple moving average of $34.94 and a 200-day simple moving average of $29.25.

Septerna (NASDAQ:SEPN - Get Free Report) last released its quarterly earnings results on Monday, August 10th. The company reported ($0.29) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.43) by $0.14. The firm had revenue of $26.75 million for the quarter, compared to analysts' expectations of $19.22 million. Septerna had a negative net margin of 24.51% and a negative return on equity of 9.59%. Analysts anticipate that Septerna will post -1.59 earnings per share for the current fiscal year.

Insider Buying and Selling at Septerna

In other Septerna news, insider Samira Shaikhly sold 2,178 shares of the firm's stock in a transaction on Monday, June 29th. The stock was sold at an average price of $35.18, for a total value of $76,622.04. Following the completion of the sale, the insider directly owned 793 shares of the company's stock, valued at $27,897.74. This trade represents a 73.31% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Daniel D. Long sold 3,334 shares of the business's stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $34.47, for a total transaction of $114,922.98. Following the transaction, the senior vice president directly owned 96,412 shares in the company, valued at approximately $3,323,321.64. The trade was a 3.34% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 47,828 shares of company stock valued at $1,584,314. 5.80% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Group One Trading LLC increased its position in shares of Septerna by 111.8% during the 4th quarter. Group One Trading LLC now owns 944 shares of the company's stock worth $26,000 after purchasing an additional 8,955 shares during the last quarter. Global Retirement Partners LLC acquired a new position in Septerna during the fourth quarter worth $35,000. Russell Investments Group Ltd. acquired a new stake in shares of Septerna in the third quarter valued at $36,000. Caitong International Asset Management Co. Ltd acquired a new position in Septerna during the 4th quarter worth about $53,000. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new position in Septerna in the 4th quarter valued at about $61,000.

About Septerna

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. GPCRs are the largest and most diverse family of cell membrane receptors and regulate physiological processes in nearly every organ system of the human body.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source